Paper

High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.

Published Sep 1, 2007 · R. Milner, A. Cantin, D. Manson

The Journal of pediatrics

146

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Highly Cited

Study Snapshot

High-dose ibuprofen significantly slows lung disease progression in cystic fibrosis patients and is generally well tolerated.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial.

References

Citations